A1-2: Cost-Effectiveness of Interleukin 28B Genotype-Guided Protease Inhibitor Therapy in Treatment-Naive Patients with Hepatitis C Virus Genotype 2 or 3
Bock, J., Fairley, K., Smith, R., Maeng, D., Pitcavage, J., Inverso, N., Williams, M.Volume:
11
Language:
english
Journal:
Clinical Medicine & Research
DOI:
10.3121/cmr.2013.1176.a1-2
Date:
September, 2013
File:
PDF, 158 KB
english, 2013